These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 25906123)
61. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas. Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639 [TBL] [Abstract][Full Text] [Related]
62. Comparison of GATA-3, Mammaglobin and GCDFP-15 Expression in Primary, Metastatic and Triple Negative Breast Carcinomas: An Indian Scenario. Rao M; Khade S; Chaudhary R; Singh P; Yadav G; Elhence P; Nalwa A; Sharma R; Goel AD Asian Pac J Cancer Prev; 2023 Feb; 24(2):509-515. PubMed ID: 36853299 [TBL] [Abstract][Full Text] [Related]
63. Efficacy of GATA3 Versus BRST2 for the Identification of Metastatic Breast Carcinoma in the Upper GI Tract: Which Performs Better? Salagean D; Streutker C; Faragalla H; Jakate K Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):501-507. PubMed ID: 29629946 [TBL] [Abstract][Full Text] [Related]
64. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin. Kanner WA; Galgano MT; Stoler MH; Mills SE; Atkins KA Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974 [TBL] [Abstract][Full Text] [Related]
65. [Mammaglobin in peripheral blood and tumor in breast cancer patients]. Bozhenko VK; Kharchenko NV; Vaskevich EF; Kudinova EA; Oorzhak AV; Rozhkova NI; Trotsenko ID Biomed Khim; 2016 May; 62(4):453-7. PubMed ID: 27563000 [TBL] [Abstract][Full Text] [Related]
66. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens. Yan Z; Gidley J; Horton D; Roberson J; Eltoum IE; Chhieng DC Diagn Cytopathol; 2009 Jul; 37(7):475-8. PubMed ID: 19217055 [TBL] [Abstract][Full Text] [Related]
67. GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung. Berg KB; Churg A Am J Surg Pathol; 2017 Sep; 41(9):1221-1225. PubMed ID: 28614203 [TBL] [Abstract][Full Text] [Related]
68. TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin. Almási S; Kuthi L; Sejben A; Vörös A; Nagy Á; Zombori T; Cserni G Virchows Arch; 2023 May; 482(5):861-868. PubMed ID: 37012444 [TBL] [Abstract][Full Text] [Related]
69. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas. Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011 [TBL] [Abstract][Full Text] [Related]
70. A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer. Tozbikian GH; Zynger DL Hum Pathol; 2019 Mar; 85():221-227. PubMed ID: 30468800 [TBL] [Abstract][Full Text] [Related]
71. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis. Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758 [TBL] [Abstract][Full Text] [Related]
72. Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall. Shen T; Zhao J; Zhao M; Taggart MW; Ramalingam P; Gong Y; Wu Y; Liu H; Zhang J; Resetkova E; Wang WL; Ding Q; Huo L; Yoon E Hum Pathol; 2022 Jul; 125():35-47. PubMed ID: 35417734 [TBL] [Abstract][Full Text] [Related]
73. In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 cases. Kawaguchi KR; Lu FI; Kaplan R; Liu YF; Chadwick P; Chen Z; Brogi E; Shin SJ Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):266-74. PubMed ID: 23958551 [TBL] [Abstract][Full Text] [Related]
74. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens. Brandler TC; Aziz MS; Rosen LM; Bhuiya TA; Yaskiv O Cancer Cytopathol; 2014 Jun; 122(6):468-73. PubMed ID: 24711443 [TBL] [Abstract][Full Text] [Related]
75. [Correlation between androgen receptor expression and surrogate molecular subtypes in invasive breast carcinoma]. Sun XJ; Zuo K; Tang SX; Lu HF; Shui RH; Yu BH; Xu XL; Cheng YF; Tu XY; Bi R; Yang WT Zhonghua Bing Li Xue Za Zhi; 2017 Jul; 46(7):476-480. PubMed ID: 28728221 [No Abstract] [Full Text] [Related]
76. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor. El-Attar NI; Gaefar HA Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663 [TBL] [Abstract][Full Text] [Related]
77. TRPS1 outperforms GATA3 in pleural effusions with metastatic breast carcinoma versus mesothelioma. Baban F; Koepplin JW; Ahmad M; Clarke-Brodber AL; Bois MC; Hartley CP; Sturgis CD Diagn Cytopathol; 2023 Aug; 51(8):488-492. PubMed ID: 37096814 [TBL] [Abstract][Full Text] [Related]
78. GATA3 expression in triple-negative breast cancers. Byrne DJ; Deb S; Takano EA; Fox SB Histopathology; 2017 Jul; 71(1):63-71. PubMed ID: 28211079 [TBL] [Abstract][Full Text] [Related]
79. Mammaglobin-A immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma. Cimino PJ; Perrin RJ Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):442-8. PubMed ID: 23958549 [TBL] [Abstract][Full Text] [Related]
80. Metaplastic and medullary mammary carcinomas do not express mammaglobin. Reyes C; Gomez-Fernández C; Nadji M Am J Clin Pathol; 2012 May; 137(5):747-52. PubMed ID: 22523213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]